Organizing Committee Member

Andrey Nikolaevych Belousov

Andrey Nikolaevych Belousov

Professor
Kharkov Medical Academy of Postgraduate Education
Ukraine

Biography

Andrey Nikolaevych Belousov graduate from Kharkov Medical Institute in 1988. Doctor of Medicine degree on speciality - An¬esthesiology and Intensive Care since 2004. The title dissertation: “Extracorporal hemocorrection using magnet-controlled sorbent in intensive therapy of intoxication syndromes in patients with hepatopancreatoduodenales dis¬eases”. Author a new medecine products – nanotechnology preparations based on magnetite nanoparticles (Fe3O4) of the size 6-12 nm (www.nanolab.com.ua): the peroral form - Micromage-B (the biologically active additive officially registration in Ukraine); Magnet-controlled sorbent brand of MCS-B for extracorporal detoxication of biological liquids (officially registration in Ukraine and was allowed for medical practice); NanoBiocorrector for intravenous application – ICNB (intracorporal nanosorbent). A.N. Belousov is author new method of extracorporal hemocorrection using magnet-controlled sor¬bent (MCS-B). Author a new program for estimation degree the severity of the patient. Based on previously developed a universal analytical system of the physiological state of the body (PHUAS) by the author proposed a new automatic program objective assessment of the severity of the patient's condition. Overall, the program can improve health of the population in terms of underfunding by the rapid and objective examination of a large quantity of people. Early on, with the help of the developed program is made possible among surveyed identify risk groups in the severity of general condition, to determine the optimal and effective options for prevention and treatment, saving time and money for the survey, use the data to correlate them with various factors influence of the environment (ecology, nutrition, addictions, drug, vaccine, methods of intensive therapy, pharmacotherapy, etc.). The published more 180 scientific works on results application of nanotechnology preparation in experimental and practical medicine. He has got 7 patents for the invention, 21 collected scientific articles, 68 works in other publications and thesis of reports at international conferences and congresses, including 35 of them abroad (Rumania, Austria, Germany, Czech, Switzerland, Hungary, Denmark, Portugal, Italy, Canada, U.S.A., China, India, and others). Author of the scientific film which focuses on the elaboration of artificial liver device and the development of a new direction in medicine – Nanotechnology. Andrey Belousov was awarded Medical Diploma of Europe “An Honorary Scholar Europe” and R. Koch medal for the scientific achievements, development of a new direction in medicine and elaboration of new method of treatment by means preparations of nanotechnology in 2008. Member of the Ukrainian and Russian Society Nanotechnology. Assistant editor-in-chief of the journal Archives of Blood Transfusion & Disorders (ABTD). Crimson Publishers, LLC, New York, USA. Member of the Editorial Board Nanosensors and Nanomaterials Journal Oscine Group Pvt Ltd., Near Manyata Embassy, Bangalore-India. Member of the Editorial Board Journal of Anaesthesia and Preoperative Care. Delaware, USA. At now Andrey Belousov - the Head of Laboratory Applied Nanotechnologies in Ukraine, DM, Professor of Department Anesthesiology, Intensive Care, Transfusiology and Hematology Kharkov Medical Academy of Postgraduate Education.

Research Area

Nanomedicine, Intensive Care, Transfusiology.

Talk to Us

Speak directly to one of our conference representatives by calling.


+0044-2033180199

Mail Us

E-mail us your questions about the conference. We will respond to your questions.


contact.steve@theannualmeet.com

Contact Us

Have questions?
We'll be in touch within 24 hours.


Contact Us

Address

EuroSciCon Ltd
35 Ruddlesway,
Windsor, Berkshire,
SL4 5SF, UK

EuroSciCon Events are produced by Euroscicon Ltd

EuroSciCon, founded in 2001 is a UK based independent life science Events Company with predominantly business and academic client base. The key strategic objective of EuroSciCon is to communicate science and medical research between academia, clinical practice and the pharmaceutical industry. Most of its events are in Europe and London or live streamed. EuroSciCon expanded its operations to international in association with Meetings International, Singapore. All major meetings of EuroSciCon and Meetings International will issue Continued Professional Education (CPD), Continued Education (CE), Continued Medical Education (CME) Credits.